Hemab Therapeutics Holdings, Inc. Common Stock (COAG) — Financial Flexibility Index
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) has a Financial Flexibility Index of -0.17x as of December 2025. Free cash flow of $-61.46 Million (operating CF $-61.48 Million minus capex $16.00K) represents 0% of total liabilities ($371.42 Million). Check asset resilience ratio of Hemab Therapeutics Holdings, Inc. Common to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hemab Therapeutics Holdings, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Hemab Therapeutics Holdings, Inc. Common Stock across 2 annual periods. Explore Hemab Therapeutics Holdings, Inc. Common cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Financial Flexibility Index for Hemab Therapeutics Holdings, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Hemab Therapeutics Holdings, Inc. Common Stock. For the full cash flow conversion analysis, see COAG cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.17x | $-61.46 Million | $-61.48 Million | $371.42 Million | ▲ +22.7% |
| 2024 | -0.21x | $-45.31 Million | $-45.59 Million | $211.55 Million | — |